FDA stops Neilgen Pharmaceuticals and Advent Pharmaceuticals from making unapproved drugs

This week FDA obtained a permanent injunction barring Neilgen Pharmaceuticals and Advent Pharmaceuticals and two of the companies officers Bharat Patel and and Pragna Patel, from manufacturing and distributing any unapproved, adulterated, or misbranded drugs

FDA noted that between the two companies they manufacturered over 50 unapproved drugs. These medicines are primarily prescription cough and cold products. Furthermore, FDA is requiring that their existing drug supply be destroyed and are advising consumers to discontinue their use.

These actions were sought after the companies failed to comply to previous warnings and continue to manufacture the unapproved drugs.

To view the entire announcement, visit the FDA website.